Viz RV/LV vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Powerful Medical

AI Verdict

Viz RV/LV and PMcardio are adjacent competitors, both focusing on cardiac conditions but utilizing different diagnostic inputs and targeting distinct, albeit sometimes overlapping, clinical scenarios. Viz RV/LV specializes in analyzing CTPA scans for pulmonary embolism risk stratification, specifically measuring the RV/LV ratio. In contrast, PMcardio interprets ECGs to detect a broader range of over 50 cardiac conditions, including STEMI and reduced LVEF.

Choose Viz RV/LV if…

Choose Viz RV/LV if your primary concern is the rapid risk stratification of patients with suspected pulmonary embolism (PE) based on CTPA scans. This tool excels at automating right and left ventricular diameter measurements to provide a crucial RV/LV ratio, facilitating quick identification of right heart strain which is a key indicator of PE severity. It's ideal for emergency medicine and radiology departments needing to expedite critical decision-making and enhance care coordination for PE patients.

View Viz RV/LV →

Choose PMcardio if…

Choose PMcardio if you require immediate and accurate interpretation of ECGs for a broad spectrum of over 50 cardiac conditions at the point of care. This AI platform is particularly well-suited for emergency physicians, general practitioners, and paramedics who need expert-level ECG analysis to confidently diagnose conditions like STEMI, arrhythmias, and reduced LVEF, even in pre-hospital settings or when specialized cardiology expertise may not be immediately available.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz RV/LV PMcardio
Pricing Not publicly available Freemium
Deployment Cloud-based Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, making it accessible on various devices. It also provides a freemium model with 5 free ECG analyses per month, allowing users to try the platform before committing to a paid plan. Viz RV/LV is cloud-based, but its pricing and accessibility for individual users are not publicly available, suggesting a more enterprise-focused deployment.

Clinical Value

PMcardio

PMcardio is CE-certified and clinically validated in over 25 studies, detecting over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with high accuracy. Viz RV/LV is FDA-cleared and focuses on automating RV/LV ratio measurements from CTPA scans for pulmonary embolism risk stratification. While valuable, PMcardio's broader diagnostic scope and extensive validation studies suggest a wider clinical utility.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model, providing 5 free ECG analyses per month and clear pricing for individual, team, and organizational plans. Viz RV/LV's pricing is not publicly available, which makes it difficult to assess its value proposition, especially for smaller practices or individual clinicians.

Enterprise Readiness

PMcardio

Both tools demonstrate enterprise readiness with HIPAA compliance and BAA availability. PMcardio, however, explicitly highlights enterprise integrations with EHR/CVIS and EMS systems, central report management, and configurable user permissions, indicating a more comprehensive suite of features for large-scale deployments. Viz.ai also serves over 1,400 hospitals and health systems, but specific enterprise features for Viz RV/LV are less detailed in the provided information.

Innovation

Tie

Both tools showcase innovation in their respective domains. Viz RV/LV offers automated RV/LV ratio measurement from CTPA scans, a crucial advancement for pulmonary embolism risk stratification. PMcardio introduces 'ECGxplainu2122' for visual AI explainability with heatmaps, enhancing trust and understanding of AI diagnoses, and also offers detection of 50+ cardiac conditions from ECGs. Given the distinct yet impactful innovations in different diagnostic areas, neither can be definitively declared a sole winner in this dimension.

Support & Docs

PMcardio

PMcardio provides a Help Center with user-friendly tutorials and manuals, and its website includes sections for regulatory information and security. While Viz.ai offers customer resources and a 'Viz Academy', the specific details about the depth and accessibility of their documentation and support for Viz RV/LV are less explicit in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz RV/LV PMcardio
Company Viz.ai Powerful Medical
Tagline AI-powered disease detection and intelligent care coordination AI that reads ECGs in seconds
Regulatory Clearance FDA-cleared (510(k) clearance for automated RV/LV ratio algorithm) CE-certified (Class IIb under EU MDR)
Primary Modality CTPA scans ECGs
Key Functionality Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement for pulmonary embolism risk stratification Interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI and reduced LVEF
Specialties Emergency Medicine, Pulmonology, Radiology Cardiology, Emergency Medicine, Internal Medicine
Clinical Validation Clinically validated (part of the Viz PE Solution, which is clinically validated) Clinically validated in more than 25 studies

Videos

Demos, reviews, and walkthroughs featuring Viz RV/LV and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz RV/LV is a seamless component of the Viz PE Solution, designed to enhance care coordination with AI-powered alerts and a HIPAA-compliant communication platform. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, allowing results to flow automatically without manual uploads.
Viz RV/LV demonstrated a sensitivity of 91.1% and specificity of 100.0% for PE clot detection and automated RV/LV ratio measurement in a study. PMcardio has been clinically validated in over 25 studies, showing 2x sensitivity for early STEMI detection, over 60% reduction in false STEMI alarms, and 98.3% accuracy for atrial fibrillation.
Viz RV/LV is designed to automate measurements and provide annotated images, which may suggest a relatively straightforward integration into existing CTPA review processes. PMcardio is designed for speed, simplicity, and clinical confidence, aiming to provide expert-level interpretations rapidly, which could imply a quick adoption for clinicians.
PMcardio offers email/help desk support, a help center with tutorials and manuals, and a dedicated scientific board. Information regarding Viz RV/LV's specific customer support quality beyond general care coordination features is not detailed in the provided information.
PMcardio for Organizations supports full audit trails, role-based access control, and tracks pathway performance across sites and teams. For Viz RV/LV, the provided information does not explicitly detail specific audit-trail features.
Viz RV/LV is specifically designed for rapid pulmonary embolism risk stratification by automating RV/LV ratio measurements from CTPA scans. PMcardio, on the other hand, interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, and provides guideline-based treatment recommendations, making it suitable for a broader range of cardiac diagnostics at the point of care.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.